Keren G, Pardes A, Eschar Y, Hansch E, Scherez J, Laniado S
Department of Cardiology, Tel Aviv Medical Center, Sackler School of Medicine, Israel.
Cardiology. 1992;81(4-5):196-206. doi: 10.1159/000175805.
The role of impaired diastolic function in determining the pathophysiology of congestive cardiomyopathy was only recently appreciated. In the present study, echocardiography and Doppler cardiography were used to determine changes in cardiac size and transmitral filling dynamics over a 1-year period in patients with congestive cardiomyopathy and determine the effect of captopril on these changes. The study population consisted of 27 patients with congestive heart failure in spite of therapy with digitalis and diuretics (NYHA class 3.2). Fifteen patients were started on placebo and 12 on captopril. Noninvasive evaluation was performed at 6-month intervals. Left ventricular size and left ventricular ejection fraction did not change significantly in either group. Forward stroke volume improved significantly only in patients on captopril compared to placebo (p < 0.05). No significant changes in transmitral flow dynamics were observed in the placebo group whereas the captopril-treated group showed a decrease in the peak velocity, flow velocity integral and rate of rapid filling wave (E) and an increase in the peak, integral and rate of filling during atrial contraction (A). The E/A ratio did not change significantly over time in the placebo group, whereas a reduction in the ratio was noted in the captopril-treated patients. These changes are sustained over 1 year with concomitant improvement in stroke volume, exercise duration and functional class.
舒张功能受损在确定充血性心肌病病理生理学过程中的作用直到最近才被认识到。在本研究中,采用超声心动图和多普勒心动图来确定充血性心肌病患者在1年期间心脏大小和二尖瓣充盈动力学的变化,并确定卡托普利对这些变化的影响。研究人群包括27例尽管接受了洋地黄和利尿剂治疗但仍有充血性心力衰竭的患者(纽约心脏协会心功能分级为3.2级)。15例患者开始服用安慰剂,12例患者开始服用卡托普利。每隔6个月进行一次无创评估。两组患者的左心室大小和左心室射血分数均无显著变化。与安慰剂组相比,仅服用卡托普利的患者每搏输出量显著改善(p < 0.05)。安慰剂组二尖瓣血流动力学无显著变化,而卡托普利治疗组的峰值速度、流速积分和快速充盈波(E)速率降低,心房收缩期充盈峰值、积分和速率增加。安慰剂组的E/A比值随时间无显著变化,而卡托普利治疗的患者该比值降低。这些变化在1年中持续存在,同时每搏输出量、运动持续时间和心功能分级得到改善。